Angion Biomedica Corp. ANGN

$ 1.0 2.04%

Quarterly report 2024-Q3
added 11-13-2024

Angion Biomedica Corp. Balance Sheet 2011-2024 | ANGN

Annual Balance Sheet Angion Biomedica Corp.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-5.98 M	1.32 M	-87.6 M	17.5 M	-	-	-	-	-	-	-	-	-
Long Term Debt	6.01 M	6.79 M	235 K	635 K	-	-	-	-	-	-	-	-	-
Long Term Debt Current	910 K	692 K	894 K	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	30.3 M	-	-	-	-	-	-	-	-	-
Total Current Liabilities	9.77 M	6.87 M	11.3 M	-	-	-	-	-	-	-	-	-	-
Total Liabilities	15.8 M	13.7 M	15 M	138 M	-	-	-	-	-	-	-	-	-
Deferred Revenue	694 K	1.44 M	2.3 M	3.94 M	-	-	-	-	-	-	-	-	-
Retained Earnings	-142 M	-107 M	-215 M	-161 M	-	-	-	-	-	-	-	-	-
Total Assets	27.1 M	22.7 M	96.5 M	47.3 M	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	12.9 M	6.16 M	88.8 M	34.6 M	-	-	-	-	-	-	-	-	-
Book Value	11.4 M	8.92 M	81.5 M	-90.4 M	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	11.4 M	-102 M	81.5 M	-90.4 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Angion Biomedica Corp.

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	5.34 M	5.56 M	5.79 M	6.01 M	6.22 M	-	-	6.79 M	186 K	202 K	219 K	235 K	-	-	-	635 K	635 K	635 K	635 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	57.4 M	17.4 M	19.6 M	15.8 M	17.7 M	-	2.1 M	13.7 M	11.1 M	11.1 M	14.1 M	15 M	45.4 M	48.2 M	46.8 M	138 M	138 M	138 M	138 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	1.31 M	350 K	627 K	694 K	1.66 M	-	-	1.44 M	-	-	653 K	2.3 M	3.66 M	5.18 M	3.79 M	3.94 M	3.94 M	3.94 M	3.94 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-180 M	-161 M	-154 M	-142 M	-133 M	-	-258 M	-107 M	-248 M	-239 M	-229 M	-215 M	-230 M	-214 M	-197 M	-161 M	-161 M	-161 M	-161 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	38.4 M	15.8 M	24.5 M	27.1 M	31 M	-	41.8 M	22.7 M	61.3 M	70.8 M	81.3 M	96.5 M	110 M	125 M	139 M	47.3 M	47.3 M	47.3 M	47.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	26 M	3.42 M	11.9 M	12.9 M	14.8 M	21.7 M	8.57 M	6.16 M	1.84 M	63.4 M	73 M	88.8 M	103 M	117 M	130 M	34.6 M	34.6 M	34.6 M	34.6 M	5.57 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-19 M	-1.65 M	4.87 M	11.4 M	13.3 M	-	39.7 M	8.92 M	50.2 M	59.8 M	67.2 M	81.5 M	64.5 M	77.2 M	92.4 M	-90.4 M	-90.4 M	-90.4 M	-90.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-19 M	-1.65 M	4.87 M	11.4 M	13.3 M	23.6 M	-110 M	-102 M	-95.7 M	59.8 M	67.2 M	81.5 M	64.5 M	77.2 M	92.4 M	-90.4 M	-90.4 M	-90.4 M	-90.4 M	-18.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency